Hughes-Visentin Alexzandra, Paul Anthea B Mahesan
University of Ottawa Faculty of Medicine, Ottawa, ON, Canada.
Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada.
Clin Med Insights Circ Respir Pulm Med. 2020 Oct 23;14:1179548420966242. doi: 10.1177/1179548420966242. eCollection 2020.
The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).
新冠疫情给常见呼吸道疾病，尤其是哮喘的症状识别、诊断、管理及随访带来了挑战。目前正在迅速开展研究，试图了解严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒如何影响哮喘患者，以及潜在的哮喘如何影响新冠病毒感染风险、症状及预后。鉴于这一独特的医学挑战，临床医生面临着逐案决定实施或继续当前哮喘治疗方案的情况。本综述将根据目前可获得的最佳证据，讨论有关哮喘与新冠病毒的现有文献（见方框1）。
